PULM - Pulmatrix Inc Net earnings per share (EPS TTM)

Symbol and logo of brand pulmatrix.com (PULM)

Pulmatrix, Inc. (PULM) maintains transparent scientific management of its trials, yet a funding shortage is forcing the company to deplete its accumulated reserves for R&D. The TTM net income per share serves as an indicator of this trend, where the current parameter equals -1.10. Business development relies on iSPERSE technology, which creates effective inhalation therapy methods for treating lung diseases.

PULM (Pulmatrix, Inc.) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/12/2026

Comprehensive metric breakdowns and analytics for Pulmatrix Inc (PULM)

- share price and expert price forecast:
Stock Quotes Pulmatrix, Inc.|PULM - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Pulmatrix, Inc.|PULM - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Pulmatrix|PULM - Total Stockholders' Equity|Market Value to Book Value Ratio pulmatrix.com|PULM - Aggregate Asset Value
- debt obligations and liquidity statistics:
Debt to Equity Pulmatrix, Inc.|PULM - Long-Term Liabilities to Equity|Short-Term Debt to Equity Ratio Pulmatrix Corp|PULM - Company Aggregate Debts|Debt to Book Capitalization Ratio Pulmatrix, Inc.|PULM - Company Long-Term Debt|Company Short-Term Debt Pulmatrix|Quick Ratio pulmatrix.com
- net income and valuation multiples indicators:
PULM - Net Profit|Future Profit Pulmatrix, Inc.|PULM - Market Price to Net Income Ratio|Future Price to Earnings Pulmatrix|PULM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Pulmatrix, Inc.|PULM - Operating income before deduction of amortization|Net earnings per share for the last 12 months Pulmatrix|PULM - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months pulmatrix.com|PULM - Earnings per share increase in current year|Earnings growth forecast for next year Pulmatrix, Inc.
Analysis of all company metrics:PULM - Pulmatrix, Inc.
Mass-produced product of Pulmatrix Corporation

TTM net income per share measures the owner's portion of the final annual financial result, excluding the impact of the total number of shares. By analyzing the trend, an investor separates fundamental growth from market volatility. The price action of the TTM annual earnings per share reveals the gap between accounting profit and actual cash flow. For Pulmatrix, Inc. (PULM), this metric reflects the commercialization efficiency of the iSPERSE platform. The success of innovations in inhalation drug delivery will directly determine the future growth of this indicator.

Competitor analysis for Pulmatrix, Inc.

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia LQDA|GLPG (Galapagos N.V.) - Earnings per one share for the last 12 months|ANIP: Net earnings per share for the last 12 months|MNKD - Net earnings per share (EPS TTM)|Amphastar Pharmaceuticals (AMPH) - Earnings per share for the last twelve months|PCRX (pacira.com) - Earnings per share for the last twelve months|Earnings per share for the last twelve months ARS Pharmaceuticals, Inc.|Net earnings per share for the last 12 months Theravance Biopharma Inc (TBPH)|Net earnings per share (EPS TTM) AQST|Net earnings per share (EPS TTM) scpharmaceuticals.com (SCPH)|Tectonic Therapeutic - Net earnings per share for the last 12 months|Earnings per share for the last four quarters TNXP (tonixpharma.com)|SXTC - Earnings per share for the last twelve months|Earnings per share for the trailing year EPRX (Eupraxia Pharmaceuticals)|BHST: Net earnings per share (EPS TTM)|EXOZ - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ORMP|Earnings per share for the last 12 months ENTX (Entera Bio Corp)|Net earnings per share for the last 12 months HYFT (MindWalk Holdings Inc.)|ABVC (ABVC BioPharma Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) CPIX (Cumberland Pharma)|Net earnings per share for the last four quarters Quantum BioPharma Corp (QNTM)|FGEN - Earnings per share for the last twelve months|TELO (telomirpharma.com) - Earnings per share for the last 12 months|RANI: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Synergy CHC|Net earnings per share for the last 12 months RLYB|Lexaria (LEXX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton Holdings Ltd (PTHL)|APM: Earnings per one share for the last 12 months|Lyra Therapeutics - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Impact BioMedical, Inc. IBO|TNFA - Earnings per share for the last twelve months|YCBD: Earnings per share for the last twelve months|PainReform Ltd. (PRFX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Altamira Therapeutics Ltd.|Earnings per share for the last twelve months Lipella Pharmaceuticals, Inc.|OptiNose Inc - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PIRS|PROC (Procaps Group Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PTPI (Petros Pharmaceuticals)|Net earnings per share (EPS TTM) qlsyy.net QLI|SLRN - Earnings per share for the last twelve months|Earnings per share for the trailing year TFFP (TFF Pharmaceuticals Inc.)